Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena Ahlfors

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Clinical Chemistry|September 26, 2019
Noninvasive Prenatal Diagnosis for Cystic Fibrosis: Implementation, Uptake, Outcome, and ImplicationsNatalie J Chandler, Helena Ahlfors, Suzanne Drury, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2010
Activating transcription factor 3 is a positive regulator of human IFNG gene expressionSanna Filén, Emmi Ylikoski, Subhash Tripathi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2007
Genome-wide identification of novel genes involved in early Th1 and Th2 cell differentiationRiikka J Lund, Maritta Löytömäki, Tiina Naumanen, et al.
Nature Immunology|April 11, 2017
Maintenance of the marginal-zone B cell compartment specifically requires the RNA-binding protein ZFP36L1Rebecca Newman, Helena Ahlfors, Alexander Saveliev, et al.
Molecular & Cellular Proteomics : MCP|August 15, 2008
Quantitative proteomics reveals GIMAP family proteins 1 and 4 to be differentially regulated during human T helper cell differentiationJan-Jonas Filén, Sanna Filén, Robert Moulder, et al.
Nature Immunology|February 1, 2011
Fate mapping of IL-17-producing T cells in inflammatory responsesKeiji Hirota, João H Duarte, Marc Veldhoen, et al.
Nature Communications|June 8, 2019
Gene expression dysregulation domains are not a specific feature of Down syndromeHelena Ahlfors, Nneka Anyanwu, Edvinas Pakanavicius, et al.
Immunity|June 10, 2014
Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditionsPaola Di Meglio, João H Duarte, Helena Ahlfors, et al.
Science Translational Medicine|October 13, 2017
An analysis of IL-36 signature genes and individuals with <i>IL1RL2</i> knockout mutations validates IL-36 as a psoriasis therapeutic targetSatveer K Mahil, Marika Catapano, Paola Di Meglio, et al.
Oncotarget|March 12, 2016
Comparative analysis of human and mouse transcriptomes of Th17 cell primingSoile Tuomela, Sini Rautio, Helena Ahlfors, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Clinical Chemistry|September 26, 2019
Noninvasive Prenatal Diagnosis for Cystic Fibrosis: Implementation, Uptake, Outcome, and ImplicationsNatalie J Chandler, Helena Ahlfors, Suzanne Drury, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2010
Activating transcription factor 3 is a positive regulator of human IFNG gene expressionSanna Filén, Emmi Ylikoski, Subhash Tripathi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2007
Genome-wide identification of novel genes involved in early Th1 and Th2 cell differentiationRiikka J Lund, Maritta Löytömäki, Tiina Naumanen, et al.
Nature Immunology|April 11, 2017
Maintenance of the marginal-zone B cell compartment specifically requires the RNA-binding protein ZFP36L1Rebecca Newman, Helena Ahlfors, Alexander Saveliev, et al.
Molecular & Cellular Proteomics : MCP|August 15, 2008
Quantitative proteomics reveals GIMAP family proteins 1 and 4 to be differentially regulated during human T helper cell differentiationJan-Jonas Filén, Sanna Filén, Robert Moulder, et al.
Nature Immunology|February 1, 2011
Fate mapping of IL-17-producing T cells in inflammatory responsesKeiji Hirota, João H Duarte, Marc Veldhoen, et al.
Nature Communications|June 8, 2019
Gene expression dysregulation domains are not a specific feature of Down syndromeHelena Ahlfors, Nneka Anyanwu, Edvinas Pakanavicius, et al.
Immunity|June 10, 2014
Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditionsPaola Di Meglio, João H Duarte, Helena Ahlfors, et al.
Science Translational Medicine|October 13, 2017
An analysis of IL-36 signature genes and individuals with <i>IL1RL2</i> knockout mutations validates IL-36 as a psoriasis therapeutic targetSatveer K Mahil, Marika Catapano, Paola Di Meglio, et al.
Oncotarget|March 12, 2016
Comparative analysis of human and mouse transcriptomes of Th17 cell primingSoile Tuomela, Sini Rautio, Helena Ahlfors, et al.
Pageof 4